Dr. Reddy's Laboratories Limited (RDY) Ownership
RDY ownership summary
as of October 18, 2026- Institutions
- 16.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 833.0M
- Float
- 3.59B shares available to trade
- Short interest
- 4.14% 28.4M shares short
- Days to cover
- 8.96 short interest up 18.8% vs prior month
- Institutions 16.00%
- Other investors 84.00%
RDY top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Robeco Institutional Asset Management BV | 2.16% | 18.0M | $235.5M | +843,218 (+4.9%) | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | 1.31% | 10.9M | $142.9M | +1.6M (+16.7%) | June 30, 2026 |
| 3 | BlackRock Inc | 1.27% | 10.6M | $138.4M | −1.0M (−8.6%) | June 30, 2026 |
| 4 | Royal Bank of Canada | 1.11% | 9.2M | $120.4M | −770,813 (−7.7%) | June 30, 2026 |
| 5 | Aikya Investment Management Ltd | 1.02% | 8.5M | $111.0M | +494,056 (+6.2%) | June 30, 2026 |
| 6 | Renaissance Technologies Corp | 0.88% | 7.3M | $96.0M | −512,700 (−6.5%) | June 30, 2026 |
| 7 | Dimensional Fund Advisors, Inc. | 0.64% | 5.3M | $69.4M | −11,183 (−0.2%) | June 30, 2026 |
| 8 | State Street Corp | 0.50% | 4.1M | $53.9M | +98,479 (+2.4%) | June 30, 2026 |
| 9 | JPMorgan Chase & Co | 0.49% | 4.1M | $53.2M | −302,021 (−6.9%) | June 30, 2026 |
| 10 | AllianceBernstein L.P. | 0.45% | 3.7M | $48.8M | +1.2M (+46.8%) | June 30, 2026 |
| 11 | Vanguard Capital Management, LLC | 0.37% | 3.1M | $40.5M | — | June 30, 2026 |
| 12 | Franklin Templeton Inc | 0.34% | 2.8M | $37.2M | −11,511 (−0.4%) | June 30, 2026 |
| 13 | Nuveen, LLC | 0.34% | 2.8M | $37.0M | +2.8M (0.0%) | June 30, 2026 |
| 14 | BNP Paribas Arbitrage, SA | 0.32% | 2.6M | $34.6M | −534,105 (−16.8%) | June 30, 2026 |
| 15 | Acadian Asset Management LLC | 0.27% | 2.3M | $29.5M | −148,518 (−6.2%) | June 30, 2026 |
| 16 | Marshall Wace Asset Management Ltd | 0.24% | 2.0M | $26.5M | −638,950 (−24.0%) | June 30, 2026 |
| 17 | Bessemer Group Inc | 0.22% | 1.9M | $24.3M | +33,936 (+1.9%) | June 30, 2026 |
| 18 | American Century Companies Inc | 0.22% | 1.8M | $23.9M | +169,550 (+10.2%) | June 30, 2026 |
| 19 | UBS Group AG | 0.20% | 1.7M | $21.7M | +106,228 (+6.8%) | June 30, 2026 |
| 20 | Schroder Investment Management Group | 0.19% | 1.6M | $21.2M | +1.4M (+793.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 8.8M shares and 9 cut 3.9M.
RDY top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | RBC Emerging Markets Equity Fund F | 0.59% | 4.9M | $63.9M | −287,100 (−5.5%) | June 30, 2026 |
| 2 | AB Emerging Markets Opportunities ETF | 0.45% | 3.8M | $49.1M | — | September 30, 2026 |
| 3 | CREF Total Global Stock Account R3 | 0.24% | 2.0M | $26.5M | — | July 31, 2026 |
| 4 | Vanguard Emerging Mkts Stock Idx Inv | 0.23% | 1.9M | $24.5M | — | August 31, 2026 |
| 5 | Avantis Emerging Markets Equity ETF | 0.22% | 1.8M | $23.7M | — | September 30, 2026 |
| 6 | Robeco QI EM Active Equities I € | 0.21% | 1.8M | $23.0M | −961,712 (−35.4%) | August 31, 2026 |
| 7 | Vanguard Global Minimum Volatility Admr | 0.18% | 1.5M | $19.9M | −251,377 (−14.2%) | June 30, 2026 |
| 8 | Templeton Emerging Mkts Invmt Tr TEMIT | 0.18% | 1.5M | $19.3M | +651,716 (+78.7%) | August 31, 2026 |
| 9 | State Street® SPDR® Portfolio EM ETF | 0.18% | 1.5M | $19.1M | — | September 30, 2026 |
| 10 | DFA Emerging Markets Core Equity 2 I | 0.16% | 1.4M | $17.6M | — | August 31, 2026 |
| 11 | Templeton Emerging Markets Equity A | 0.13% | 1.1M | $13.8M | +568,510 (+116.1%) | August 31, 2026 |
| 12 | Robeco QI Emerging Cnsrv Eqs I € | 0.12% | 972K | $12.7M | −547,700 (−36.0%) | August 31, 2026 |
| 13 | Templeton Emerging Markets A(Ydis)USD | 0.11% | 953K | $12.5M | +447,411 (+88.5%) | August 31, 2026 |
| 14 | Vanguard Total Intl Stock Index Inv | 0.10% | 874K | $11.4M | — | August 31, 2026 |
| 15 | JPM Emerging Mkts Opps A acc USD | 0.09% | 753K | $9.8M | −263,874 (−25.9%) | August 31, 2026 |
| 16 | Nuveen Emerging Markets Eq R6 | 0.09% | 739K | $9.7M | — | August 31, 2026 |
| 17 | onemarkets J.P. Morgan Em Cntrs E EURAcc | 0.07% | 590K | $7.7M | +75,430 (+14.6%) | July 31, 2026 |
| 18 | RAM (Lux) Sys Emg Mkts Equities B USD | 0.07% | 580K | $7.6M | +46,051 (+8.6%) | June 30, 2026 |
| 19 | Dimensional EM LrgCap Core Eq USD Acc | 0.07% | 553K | $7.2M | — | August 31, 2026 |
| 20 | DFA Emerging Markets I | 0.06% | 506K | $6.6M | +9 (+0.0%) | April 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
RDY shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns RDY
Institutional investors own 16.0% of Dr. Reddy's Laboratories's shares and insiders 0.00%. The largest holder is Robeco Institutional Asset Management BV with 2.16% of the shares (18.0M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 9 reduced their stake in the latest filings. Short interest is 4.14% of the float, or 8.96 days of average trading volume. The share count rose 387.4% since 2014.
Related: RDY analyst forecast, RDY key metrics, RDY dividend history. See the RDY stock overview for the latest quote and news.
RDY ownership FAQ
Who owns the most Dr. Reddy's Laboratories stock?
The largest shareholders of Dr. Reddy's Laboratories are Robeco Institutional Asset Management BV (2.16%), Morgan Stanley - Brokerage Accounts (1.31%), BlackRock Inc (1.27%), Royal Bank of Canada (1.11%), Aikya Investment Management Ltd (1.02%).
What percentage of Dr. Reddy's Laboratories is owned by institutions?
Institutions hold 16.0% of Dr. Reddy's Laboratories's shares outstanding; insiders hold 0.00%.
Which funds own Dr. Reddy's Laboratories?
The largest fund holders of Dr. Reddy's Laboratories are RBC Emerging Markets Equity Fund F (0.59%), AB Emerging Markets Opportunities ETF (0.45%), CREF Total Global Stock Account R3 (0.24%), Vanguard Emerging Mkts Stock Idx Inv (0.23%), Avantis Emerging Markets Equity ETF (0.22%).
What is Dr. Reddy's Laboratories's short interest?
28.4M shares of Dr. Reddy's Laboratories were sold short, 4.14% of the float; at the average daily volume it would take 8.96 days to cover.
How many shares of Dr. Reddy's Laboratories are outstanding?
Dr. Reddy's Laboratories has 833.0M shares outstanding, of which 3.59B are in the public float.